Jun 30, 2014
Jun 25, 2014
1 Million Dollar Astra Zeneca grant was funded for studying the effects of Ticagrelor in patients with peripheral arterial disease using intravascular optical coherence tomography. Dr. Mehmet has recently secured an investigator initiated clinical research grant from Astra Zeneca. Peripheral arterial disease (PAD) is the leading cause of limb loss in the United States. Although the known conventional risk factors for coronary artery disease are also associated with development of PAD, postmortem data on amputee’s suggest that there may be a different pathology for PAD, mainly intraluminal clot formation and progression. The preliminary work that we have done in our PAD patients at AHH showed that intraluminal clot formation indeed plays a significant role in PAD both in early as well as late phases of the disease. With the AZ grant, we will study the effects of Ticagrelor which is the most potent antiplatelet agent that is available in the market, the long term patency and clot burden in patients with PAD following stent placement. Our hypothesis is that with use of Ticagrelor there will be less intraluminal clot formation and increased patency of stents in patients with PAD. Dr. Lendel and Cawich will also be the coinvestigators of this important study.
Apr 07, 2014
Apr 04, 2014
Mar 07, 2014
Feb 21, 2014
Feb 17, 2014
Feb 10, 2014
Feb 07, 2014
Dr. Flaherty has been interviewed by THV Channel 11 about sleep apnea and heart disease.
Feb 07, 2014
Arkansas Heart Hospital’s Keep the Beat program was featured on KATV’s evening news on February 6th! Thanks for a great story, Justin Lewis!
Jan 29, 2014
Nov 21, 2013
FOR IMMEDIATE RELEASE
Contact: Rachelle Lamphere
Director of Marketing
New diagnostic system offers advanced insight into patient’s arteries to improve diagnosis and treatment of coronary artery disease
Little Rock, AR – November 18, 2013 – Arkansas Heart Hospital is the only publically accessible hospital in central Arkansas now offering St. Jude Medical’s ILUMIEN PCI Optimization System as a treatment option for patients suffering from coronary artery disease (CAD). The ILUIMIEN system is the first and only integrated diagnostic technology that combines optical coherence tomography (OCT) and fractional flow reserve (FFR) technologies on one platform.
Using the combined ILUMIEN system, physicians at Arkansas Heart Hospital gain advanced physiological and anatomical insights that can improve the diagnosis and treatment of CAD.
Patients with coronary artery disease experience decreased oxygen delivery to the heart due to plaque or cholesterol build-up inside arteries. Dr. Ian Cawich, an interventional cardiologist at Arkansas Heart Hospital was the first to use ILUMIEN at the hospital.
“The key to optimizing treatment of coronary artery disease is knowing which blockage needs treatment and how to treat it,” said Dr. Cawich. “The ILUMIEN system allows me to have the information I need in one place and helps me accurately diagnose and optimize therapy for my patients.”
With the integration of these two technologies, Arkansas Heart Hospital physicians can identify the precise measurement and dimensions of culprit narrowings responsible for obstructing blood flow to a patient’s’ heart, as well as determine vessel size and structure.
About Arkansas Heart Hospital
Arkansas Heart Hospital is a nationally recognized and award winning hospital dedicated to the prevention, diagnosis and treatment of cardiovascular disease. Arkansas Heart Hospital offers advanced technology teamed with highly trained support staff and Arkansas’ leading cardiologists and cardiovascular surgeons. Arkansas Heart Hospital is the only Accredited Chest Pain Center in central Arkansas, and is a cardiac training center for the American Heart Association. For more information, please visit www.arheart.com
Sep 26, 2013
Arkansas Heart Hospital Launched its Health Information System in Record Time
Aug 27, 2013
A willing heart and helping hand is sometimes all it takes. Why not volunteer your time and make a difference? Head over to our volunteer form to sign up today!
Jul 25, 2013
Jul 23, 2013
Arkansas Heart Hospital is pleased to announce the opening of our new clinic in Hot Springs.
Saturday, July 27, 2013
Jun 26, 2013
PVI is excited to be bringing free peripheral vascular disease (PVD) screenings to Vilonia and Cabot! Open to anyone who is interested, the screenings consist of a non-invasive, 15 minute ABI test to help determine if you have poor circulation in your legs. There are NO needles or unpleasant sticks plus you receive your results at the end of the test! Professional staff will also be available to answer any questions that you may have.
PVD is a common circulatory problem that results in decreased blood flow to the legs. It is estimated that PVD affects at least 8-12 million Americans today and most do not have symptoms. If symptoms are present, they can include pain in the legs when walking, slow healing wounds, and feeling of numbness or coldness. PVD is known to be a predictor of heart attack and stroke. If untreated, PVD can lead to amputation. Early detection is the key to preventing these complications.
Friday, 7/19/13 from 9-1
Vilonia Senior Center
10 Bise Street
Vilonia, AR 72173
Appointment is needed: Call 501-978-3746
Friday, 8/2/13 from 9-1
Cabot Senior Center
600 North Grant Street
Cabot, AR 72023
Appointment is needed: Call 501-843-2196 or 501-553-7966
We hope to see you there!
May 20, 2013
TRU, Transradial University, wants to spotlight the Arkansas Heart Hospital for their advances in radial artery access procedures. In conjunction with Jeff Martin from Cath Lab Digest, TRU filmed Dr. Mego, Dr. Rollefson and Taylor Thompson, RN, RCIS, explaining what we do at Arkansas Heart Hospital Clinic with our national radial training program as well as all aspects of radial arteriography. Our radial training program at our clinic has trained over 100 practitioners from across the country; many as far away as Fairbanks, Alaska. Arkansas Heart Hospital Clinic is the premier radial training site in the United States.
Apr 29, 2013
More than one million cardiac catheterizations are performed in the United States each year. Some are diagnostics, and others are interventional (angioplasty). Both procedures start the same, with a need to gain access to a patient’s arteries in order to determine if there is a blockage that may be restricting the flow of the blood and where the blockage may be. In the majority of procedures in the United States, access is made through the femoral artery located in the groin. Outside the United States, the preferred method in many countries is to go through the radial artery in the wrist (transradial access). This method is beginning to increase in the U.S., as well. Arkansas Heart Hospital is the state’s leader in the access strategy with Dr. William Rollefson who has been utilizing this method for four years.
Dr. Rollefson has recently taken part in an on-line continuing education event aimed at educating clinicians on the potential cost benefits of adopting a trans-radial PCI program. The event can be viewed by clicking the link below:
Apr 14, 2013
Arkansas Heart Hospital is proud to sponsor the Cardiac Classic once again in 2013. We had our inaugural ride last April and were thrilled with 261 riders joining us for a beautiful April ride.
Apr 14, 2013
Congratulations to Dr. Mehmet, Dr. Rollefson and Dr. Mego on the publication of their study, “Percutaneous Implantation of a Ventricular Partitioning Device for Treatment of Ischemic Heart Failure” in a leading cardiology journal with worldwide circulation.
Click here to view a PDF of the study.
Mar 19, 2013
Congratulations to Linda Murphy, Jessica Fite, and Mai Nguyen of PVI for being accepted into various UAMS education programs! Jessica and Mai will be attending the physician assistant program and Linda will be attending the MD program. We appreciate everything that these young women have contributed to Arkansas Heart Hospital and PVI and we wish them the very best! They will truly be missed!
Feb 21, 2013
Sat, February 23 2013
Join us for an expanded heart screening. We will be doing the Heart Attack Risk Assessment: Blood Pressure, Blood Sugar, Total Cholesterol, HDL, LDL, Triglycerides and Coronary Risk Ratio.
In addition to that screening, we are adding two additional screenings:
1. Peripheral Vascular Screening - checking out your legs for circulation, poor circulation could be a sign of Peripheral Vascular Disease.
2. HSCT - this is a 7 second CT scan of the heart. It will give us a calcium score (the amount of calcium in and around your coronary arteries.) A high calcium score can be an indicator of heart disease long before you begin to exhibit any warning signs.
Arkansas Heart Hospital Lobby
8am - 1pm
MUST HAVE AN APPOINTMENT: CALL 501-219-7060 TO SCHEDULE YOUR TIME.
Feb 19, 2013
Peripheral vascular disease (PVD) is an often overlooked and unpublicized disease that affects blood vessels outside of the heart and brain. This serious medical condition can result in the narrowing of arteries causing loss of blood circulation in the body’s extremities, leading to gangrene and possible limb amputation. Individuals diagnosed with PVD are also at greater risk for heart attack and stroke. If detected early, treatment is usually highly effective. DO NOT WAIT. Trust the Peripheral Vascular Institute of Arkansas to help identify your risk for PVD. Using the latest technology and equipment, our team can help you determine and understand the facts about your vascular health before it’s too late.
To learn more please visit our PVI website.
Feb 01, 2013
Do you have leg pain? Arkansas Heart Hospital is proud to introduce the first and only peripheral vascular institute of Arkansas (PVI). Click here to learn more about peripheral vascular disease (PVD) and what PVI can do to help you.
Dec 28, 2012
The Little Rock, North Little Rock, and Russellville clinics will open at 10:00am again today.
Dec 27, 2012
Our Little Rock Clinic will be open at 10:00 today and all of our other satellite clinics will be open as usual. The hospital has been, and will remain, open.
Dec 26, 2012
The Arkansas Heart Hospital Clinic and ALL Satellite Clinics are closed today, due to inclement weather. NOTE: The main hospital is OPEN.
Nov 26, 2012
Arkansas Heart Hospital CFO Mark Hartman has been named Arkansas Business’ 2012 Large Company CFO of the Year.
Read more about Mark Hartman here.
Read about the finalists here.
Sep 17, 2012
Congratulations to Dr. Mehmet, who is the winner for this year’s Northwestern University Young Investigator Award. He won the award for his clinical research on identification of vulnerable plaque in patients with carotid artery stenosis using optical coherence tomography. He has been invited to present his research in Chicago at Northwestern University.
Aug 06, 2012
“Kiss a Pig” Contest
Dr. Vasili Lendel contestant for American Diabetes Association Gala Event
The Greens at North Hills
7400 Highway 107
sherwood, ar 72120
Friday, September 21, 2012 at 1:00 pm
Scramble (4 man teams)
$125.00 per person or $500.00 per team.
Includes: Greens fee, cart rental, lunch, range balls, and prizes.
Individual registrations are welcome.
Make checks payable to:
Arkansas Heart Hospital
Please contact Sheron Wiess at 501-350-6514 or Sheron.Wiess@arheart.com for more information.
Jul 30, 2012
WASHINGTON, D.C. (July 30, 2012) – New structural heart disease (SHD) interventions over the past decade are driving demand for advanced interventional cardiology training programs, but training in this specialized area remains in its infancy, according to new survey results released today by the Society for Cardiovascular Angiography and Interventions (SCAI)‘s Structural Heart Disease Early Career Task Force and e-published in Catheterization and Cardiovascular Interventions. The survey found that while the majority of interventional cardiology training programs involve structural interventions – such as transcatheter aortic valve replacement, pulmonic valve implantation and mitral valve repair – few offer dedicated SHD fellowships.
“Structural heart disease care has changed significantly in recent years, and new treatments require specialized training on complex interventions,” said Mehmet Cilingiroglu, M.D., FSCAI, associate professor of Medicine at the University of Pittsburgh Medical Center Heart and Vascular Institute in Pennsylvania and an author of the paper. “Our survey found SHD training remains in its early stages. As we advance care for patients, it’s essential that we establish structured training programs with standardized requirements that can help new interventional cardiologists build their skills in this important area.”
The survey of 50 Accreditation Council for Graduate Medical Education (ACGME) accredited interventional cardiology programs found:
Based on the survey, the task force called for a structured curriculum for SHD training with uniform requirements. “As interventional cardiology advances, so do our education and training needs,” said J. Jeffrey Marshall, M.D., FSCAI, FACC, SCAI president and medical director of the cardiac catheterization laboratory at Northeast Georgia Heart Center. “SCAI is committed to continuously improving education programs to equip cardiologists with the necessary tools and resources to provide the best care for our patients.” The SCAI Structural Heart Disease Early Career Task Force was established in 2011 to provide a forum for interventional cardiologists who are seeking advanced SHD training or are currently involved in a SHD program.
Jun 19, 2012
Jun 19, 2012
Mar 12, 2012
LITTLE ROCK, Ark. (KTHV)—Arkansas Heart Hospital becomes the first place in the U.S. to use a revolutionary device that helps patients suffering from peripheral artery disease or PAD.
Mar 12, 2012
LITTLE ROCK, AR - It’s no bigger than a strand of hair, but it’s changing the way cardiologists at the Arkansas Heart Hospital operate. “It’s like working with your eyes open as opposed to working with your eyes closed,” said Dr. Ian Cawich, one of the first cardiologists in the U.S. to use the device. For the first time in the country, doctors at the Arkansas Heart Hospital are operating with the Ocelot - the first ever catheter with a camera on the end allowing doctors to see inside a clogged artery versus just the two dimensional X-ray view.
Mar 12, 2012
LITTLE ROCK, Ark. (KTHV) - Arkansas Heart Hospital and Interventional Cardiologists Dr. David Mego and Dr. William Rollefson became the first in this region of the United States to implant the SAPIEN transcatheter aortic heart valve as an FDA-approved standard of care.
Mar 07, 2012
FOR IMMEDIATE RELEASE
Contact: Rachelle Lamphere
Director of Marketing
Arkansas Heart Hospital
Little Rock, AR March 6, 2012— Arkansas Heart Hospital announces its participation in CONNECT II, a global clinical trial conditionally approved by the FDA that gives physicians access to a sophisticated new imaging technology tool to fight Peripheral Arterial Disease (PAD). The technology, called Ocelot, helps to eliminate the need for bypass surgeries and/or amputations in patients with the disease. Each year, nearly 200,000 amputations occur as a result of PAD and many of them can be avoided.
PAD, affecting between 8 and 12 million adults in the U.S. alone, is caused by a build-up of plaque in the arteries that blocks blood flow to the legs and feet. Because some blockages can become so severe and difficult to penetrate with traditional catheters, patients (unaware of other options) often resort to undergo extremely invasive bypass surgeries that result in even higher health risks and lengthy, painful recoveries. Patients over 50 often face amputation, the worst-case scenario associated with PAD.
Ian Cawich, M.D., Interventional Cardiologist and David Mego, M.D., Interventional Cardiologist and Director of Interventional Cardiology at Arkansas Heart Hospital, as part of CONNECT II, will use Ocelot on enrolled patients to help restore blood flow in completely blocked arteries in patients’ legs through a simple two-millimeter skin incision, helping to avoid amputation. They are also leading other co-investigators at Arkansas Heart Hospital.
“This technology is a big leap forward, combining inside the artery imaging and tools to deal with the blockage. For the first time, we’ve been able to combine imaging inside the artery while treating the vessel at the same time,” said Dr. Bruce Murphy, M.D., PhD, President and CEO of Arkansas Heart Hospital. “That advanced technology enables the cardiologist to visualize their progress in real time. The imaging technology is on the catheter, which is inserted into the patient.”
Ocelot is the first-ever CTO crossing catheter that can access exact regions of the peripheral vasculature where the blockages occur, while simultaneously providing physicians with visualization for real-time navigation during an intervention.
CONNECT II trial procedures using Ocelot will permit patients to leave the hospital within hours of the minimally invasive procedure and return to normal activities within a few days.
CONNECT II is a prospective, multi-center, non-randomized global clinical study that will evaluate Ocelot on 100 PAD patients with femoropopliteal CTO lesions at 17 sites, including three in the EU, where Ocelot received CE Mark in 2011. To learn more about CONNECT II and the first global patients enrolled, visit: http://avinger.com/newsroom.
Often dismissed as normal signs of aging, symptoms of PAD include painful cramping, numbness, or discoloration in the legs or feet. Hospitalization costs of PAD alone are estimated to exceed $21 billion annually, largely due to late detection and patients experiencing a decreased quality of life from invasive bypass surgery and/or amputation.
Arkansas Heart Hospital encourages those that are experiencing any of the above symptoms to ask their doctor about their risks for PAD, as early detection is the key to saving limbs.
Founded in 2007 by renowned cardiologist and medical device entrepreneur Dr. John B. Simpson, Avinger develops next-generation catheter-based technologies for the treatment of peripheral artery disease (PAD). Leveraging core competencies in medical device catheter engineering and intravascular Optical Coherence Tomography (OCT), Avinger markets Wildcat and Kittycat catheters, and received CE Mark in 2011 to market Ocelot, the first ever real-time OCT crossing catheter. www.avinger.com.
Mar 01, 2012
Just fifteen years ago, Arkansas Heart Hospital came into existence… a hope… a vision… a promise.
The dream became a reality only through the dedication and diligence of the physicians and staff, as they are the “heart” behind the miracles that walk out of these doors daily.
We salute you, Arkansas Heart Hospital, and the promise of another 15 years!
Bruce Murphy, MD, PhD
President and CEO
Arkansas Heart Hospital
Feb 29, 2012
Join us for the 2012 Cardiac Classic Bike Ride and Central Arkansas Heart Walk on April 21. You can walk, run or ride with us!
Jan 12, 2012
The Cardiac Needs of the Patient Come First
Little Rock, AR - January 12, 2012 Saline Memorial Hospital has partnered with Arkansas Heart Hospital to create a highly coordinated partnership capable of ensuring high-quality, cost-effective cardiac care. By building on the already strong reputation and resources of Saline Memorial Hospital, Arkansas Heart Hospital will continue to develop existing services, making them more efficient while introducing new services to respond to patient needs. Cardiologists from Arkansas Heart Hospital will see patients in Benton five days a week providing diagnostic, non-invasive testing and invasive services. They will also provide 24/7 call coverage to the Saline Memorial Hospital Emergency Department for acute cardiac care needs.
This is a promising new chapter for Saline Memorial Hospital and for patients, said Carla Robertson, interim CEO. This new partnership with Arkansas Heart Hospital along with the existing services provided by Saline Heart Group will enhance cardiovascular care for our community.
Saline Memorials partnership with Arkansas Heart Hospital provides patients with the opportunity to receive care from visiting specialists and allows seamless access to specialty services at Arkansas Heart Hospital when appropriate. The close relationship with Arkansas Heart Hospital is also evident through professional relationships between physicians, allied health staff, administrators and all employees who work collaboratively throughout the system.
Arkansas Heart Hospital will provide an unparalleled experience as the most trusted partner for cardiac care. Arkansas Heart Hospital is committed to providing quality healthcare close to home with clinics in 30 communities throughout the state of Arkansas. Our goal is to provide this community high quality cardiac care and the partnership of Arkansas Heart Hospital and Saline Memorial Hospital just makes sense. There is a long rich history of several decades of physicians from both hospitals collaborating in patient care. The opportunity to rekindle this relationship is exciting and one that both partners are looking forward to, said Dr. Bruce Murphy, President and CEO of Arkansas Heart Hospital.
Aug 01, 2011
Aug 01, 2011
Official press release on name change of Little Rock Cardiology Clinic to Arkansas Heart Hospital Clinic.
May 04, 2011
Arkansas Heart Hospital has been awarded designation as American Heart Association’s Gold Start! Fit-Friendly Company!
Feb 01, 2011
Click here to read the article from Medical News of Arkansas, and download the article in PDF format.